BRCA1/2 — Assessment of the Risk of Hereditary Breast and Ovarian Cancer - 50% off

BRCA1/2 — Assessment of Hereditary Breast and Ovarian Cancer Risk

50% discount on BRCA1/2 genetic testing

Some types of cancer may be associated with an inherited genetic predisposition. Testing the BRCA1 and BRCA2 genes allows the identification of pathogenic variants that may be associated with an increased risk of hereditary breast and ovarian cancer.

As part of our special offer, BRCA1/2 genetic testing is available at a 50% discount.

Who may benefit from this test?

Genetic testing may be indicated in cases of:

• a family history of breast and/or ovarian cancer;
• breast or ovarian cancer diagnosed at a young age among family members;
• an identified BRCA1/BRCA2 mutation in biological relatives;
• the need to assess hereditary cancer risk and establish an appropriate preventive monitoring strategy;
• a recommendation from a geneticist, oncologist or gynecologist.

Why is genetic testing important?

Identifying an inherited predisposition allows for a more accurate assessment of individual risk and, together with a healthcare professional, helps determine an appropriate strategy for monitoring, prevention and early detection.

BRCA1 and BRCA2 are genes involved in the repair of DNA damage. Pathogenic variants in these genes can impair DNA repair processes and may be associated with an increased risk of developing certain types of cancer.

If there is a history of breast or ovarian cancer in your family, discuss the appropriateness of genetic testing with your doctor.

Take advantage of the special offer — 50% discount on BRCA1/2 genetic testing.

For more information about the test and the offer conditions, contact the Call Center: 078 903 999.